• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Allogeneic gamma delta T cells as adoptive cellular therapy for hematologic malignancies”.
    No. Publication Date Citing Article
    1 2023 Léa Rimailho, Carla Faria, Marcin Domagala, Camille Laurent, Christine Bezombes, Mary Poupot. γδ T cells in immunotherapies for B-cell malignancies, Frontiers in Immunology. 2023; 14: 1200003.  https://doi.org/10.3389/fimmu.2023.1200003
    2 2023 In Kang, Yumin Kim, Heung Kyu Lee. γδ T cells as a potential therapeutic agent for glioblastoma, Frontiers in Immunology. 2023; 14: 1273986.  https://doi.org/10.3389/fimmu.2023.1273986
    3 2024 Noah Eckman, Anahita Nejatfard, Romola Cavet, Abigail K. Grosskopf, Eric A. Appel. Biomaterials to enhance adoptive cell therapy, Nature Reviews Bioengineering. 2024; 2: 408.  https://doi.org/10.1038/s44222-023-00148-z
    4 2022 Rama Rao Malla, Priyamvada Bhamidipati. γδ T Cell-Mediated Immune Responses for Cancer Therapy: Special Focus on Breast Cancer , Critical Reviews in Immunology. 2022; 42: 9.  https://doi.org/10.1615/CritRevImmunol.2023047363
    5 2023 Ying Fang, Yichen Zhu, Adam Kramer, Yuning Chen, Yan-Ruide Li, Lili Yang. Graft-versus-Host Disease Modulation by Innate T Cells, International Journal of Molecular Sciences. 2023; 24: 4084.  https://doi.org/10.3390/ijms24044084
    6 2024 Megan Yuan, Wenjun Wang, Isobel Hawes, Junwen Han, Zhenyu Yao, Alice Bertaina. Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy, Frontiers in Immunology. 2024; 15: 1360237.  https://doi.org/10.3389/fimmu.2024.1360237
    7 2024 Adishwar Rao, Akriti Agrawal, Gautam Borthakur, Venkata Lokesh Battula, Abhishek Maiti. Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies, Journal for ImmunoTherapy of Cancer. 2024; 12: e007981.  https://doi.org/10.1136/jitc-2023-007981
    8 2023 Claudia Giannotta, Federica Autino, Massimo Massaia. Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?, Frontiers in Immunology. 2023; 14: 1167443.  https://doi.org/10.3389/fimmu.2023.1167443
    9 2024 Caroline Lonez, Eytan Breman. Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?, Cells. 2024; 13: 146.  https://doi.org/10.3390/cells13020146
    10 2023 Derek Lee, Zachary Spencer Dunn, Wenbin Guo, Carl J. Rosenthal, Natalie E. Penn, Yanqi Yu, Kuangyi Zhou, Zhe Li, Feiyang Ma, Miao Li, Tsun-Ching Song, Xinjian Cen, Yan-Ruide Li, Jin J. Zhou, Matteo Pellegrini, Pin Wang, Lili Yang. Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering, Nature Communications. 2023; 14: 6942.  https://doi.org/10.1038/s41467-023-42619-2
    11 2023 John Anderson, Marta Barisa. Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers, Molecular Therapy - Oncolytics. 2023; 30: 151.  https://doi.org/10.1016/j.omto.2023.08.003